Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/14/24 18:07 | 6/14/24 | RGEN | Health | BioPrd | Biological Products, (No Diag | Madaus Martin D | MA | D | P | 202 | 124.94 | 0 | 2 | 54 | 5 | D | |||||||||||||||
6/14/24 17:42 | 6/14/24 | RGEN | Health | BioPrd | Biological Products, (No Diag | Barthelemy Nicolas | MA | D | P | 151 | 125.45 | 0 | 1 | 35 | 5 | D | |||||||||||||||
6/14/24 17:41 | 6/14/24 | RGEN | Health | BioPrd | Biological Products, (No Diag | Hunt Anthony | MA | O | CEO | P | 248 | 124.08 | 0 | 2 | 1 | 165 | D | ||||||||||||||
5/8/23 21:15 | 5/4/23 | RGEN | Health | BioPrd | Biological Products, (No Diag | Madaus Martin D | MA | D | P.m | 238 | 158.84 | 0 | 2 | 999% | 2 | M | |||||||||||||||
12/15/22 06:55 | 3/16/22 | RGEN | Health | BioPrd | Biological Products, (No Diag | Eglinton Manner Carrie | MA | D | P | 109 | 175.02 | 0 | 1 | 42 | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |